Shilpa Paul

7PUBLICATIONS
24CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Phycology (incl. marine grasses)Haematological tumoursAfrican languages
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 29, 2024
Blinatumomab for the treatment of acute lymphoblastic leukemia in a real-world setting: clinical vignettes.

Shilpa Paul, Elias Jabbour, E Dan Nichols

|Aug 02, 2024
Optimal frontline therapy of chronic myeloid leukemia today, and related musings.

Hagop M Kantarjian, Kebede Begna, Elias J Jabbour

|Oct 12, 2022
Incidence of adverse effects in patients receiving ponatinib with concomitant azole antifungals.

Kayleigh R Marx, Caitlin R Rausch, Alexandra R Lovell

|May 28, 2022
Intrathecal prophylaxis with 12 versus 8 administrations reduces the incidence of central nervous system relapse in patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia.

Shilpa Paul, Hagop Kantarjian, Koji Sasaki

|May 11, 2021
Clinical and molecular characteristics and treatment patterns of adolescent and young adult patients with chronic lymphocytic leukaemia.

Hua-Jay J Cherng, Nadya Jammal, Shilpa Paul

|Jul 21, 2020
Atypical cases of necrotizing sweet syndrome in patients with myelodysplastic syndrome and acute myeloid leukaemia.

Shilpa Paul, Nadya Jammal, Neal Akhave

Pageof 2

Frequent Collaborators

3 joint publications

Nitin Jain

3 joint publications

Elias Jabbour

2 joint publications

Guillermo Garcia-Manero

2 joint publications

Hagop M Kantarjian